Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Inspira Technologies Oxy B.H.N. Ltd. (IINN) Stock Forecast & Price Prediction Israel | NASDAQ | Healthcare | Medical Devices
$0.50
-0.01 (-2.56%)Did IINN Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Inspira Technologies is one of their latest high-conviction picks.
Based on our analysis of 4 Wall Street analysts, IINN has a bullish consensus with a median price target of $5.00 (ranging from $5.00 to $5.00). The overall analyst rating is N/A (N/A/10). Currently trading at $0.50, the median forecast implies a 910.1% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for IINN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 2, 2025 | Litchfield Hills | Theodore O'Neill | Buy | Initiates | $2.00 |
| Jan 25, 2023 | Aegis Capital | David Bouchey | Buy | Maintains | $13.00 |
| Dec 31, 2021 | Aegis Capital | Buy | Maintains | $N/A | |
| Nov 1, 2021 | Aegis Capital | Nathan Weinstein | Buy | Maintains | $10.00 |
| Aug 26, 2021 | Aegis Capital | Buy | Initiates | $N/A |
The following stocks are similar to Inspira Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops innovative respiratory support solutions.
The company focuses on creating advanced medical devices for respiratory care, specifically targeting acute respiratory failure. It generates revenue primarily through the sale of its flagship minimally invasive blood oxygenation device to hospitals and emergency facilities.
Inspira Technologies aims to improve patient outcomes and enhance healthcare standards by providing solutions that allow patients to remain conscious and mobile. The technology has potential market significance due to the increasing demand for advanced health-tech solutions in critical care.
Healthcare
Medical Devices
34
Mr. Dagi Shahar Ben-Noon
Israel
2021
Inspira Technologies OXY B.H.N. Ltd (NASDAQ: IINN, IINNW) announced the appointment of a new executive on April 14, 2026. Further details on the appointee were not provided.
Leadership changes can impact company direction, strategy, and investor confidence, potentially affecting stock performance and market perception.
Inspiraโข Technologies (Nasdaq: IINN) has begun implementing its AME technology with a major U.S. company, enhancing its entry into quantum computing and advanced tech markets.
Inspira's partnership with a top U.S. firm to implement its AME technology signals strong demand and validation for its innovations, potentially driving revenue growth and enhancing market position.
The Company has acquired intellectual property, customer-related assets, and commercial operations, enhancing its strategic position for future growth.
The acquisition of key assets enhances the company's strategic positioning, potentially boosting future growth and profitability, which can positively impact stock performance.
Inspira Technologies (Nasdaq: IINN) has entered the quantum computing sector, utilizing its additive manufactured electronics platform for a new 3D architecture in dilution cryostats.
Inspira's entry into quantum computing and development of a 3D architecture may enhance its growth potential, addressing key industry challenges and attracting investor interest.
Inspira Technologies (Nasdaq: IINN) has terminated its sales agreement with A.G.P./Alliance Global Partners and its Standby Equity Purchase Agreement with YA II PN, Ltd.
Termination of key sales and equity agreements may signal operational challenges or strategic shifts for Inspira Technologies, potentially affecting stock performance and investor confidence.
The company has shown clinical validation and early signs of commercial success, aiming for significant revenue growth by 2026.
Clinical validation and early commercial traction signal strong future revenue potential, enhancing investor confidence and likely affecting stock valuation positively.
Based on our analysis of 4 Wall Street analysts, Inspira Technologies Oxy B.H.N. Ltd. (IINN) has a median price target of $5.00. The highest price target is $5.00 and the lowest is $5.00.
According to current analyst ratings, IINN has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.50. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict IINN stock could reach $5.00 in the next 12 months. This represents a 910.1% increase from the current price of $0.50. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company focuses on creating advanced medical devices for respiratory care, specifically targeting acute respiratory failure. It generates revenue primarily through the sale of its flagship minimally invasive blood oxygenation device to hospitals and emergency facilities.
The highest price target for IINN is $5.00 from at , which represents a 910.1% increase from the current price of $0.50.
The lowest price target for IINN is $5.00 from at , which represents a 910.1% increase from the current price of $0.50.
The overall analyst consensus for IINN is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.00.
Stock price projections, including those for Inspira Technologies Oxy B.H.N. Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.